Total submissions: 5
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Athena Diagnostics | RCV003558436 | SCV000612348 | likely pathogenic | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | The frequency of this variant in the general population is consistent with pathogenicity. (http://gnomad.broadinstitute.org) This variant has been identified in at least one individual with clinical features associated with this gene. Assessment of experimental evidence suggests this variant results in abnormal protein function. (PMID: 32620747) |
| Women's Health and Genetics/Laboratory Corporation of America, |
RCV000516772 | SCV004037720 | uncertain significance | not specified | 2023-08-29 | criteria provided, single submitter | clinical testing | Variant summary: ANO10 c.512T>C (p.Phe171Ser) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 251062 control chromosomes (gnomAD). c.512T>C has been reported in the literature in individuals affected with cerebellar ataxia (Renaud_2014, Benkirane_2021), and one was reported as compound heterozygous with a (likely) pathogenic variant. These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 25089919, 34234304). Two submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. Both submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. |
| Labcorp Genetics |
RCV003558436 | SCV004292685 | likely pathogenic | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 171 of the ANO10 protein (p.Phe171Ser). This variant is present in population databases (rs373386030, gnomAD 0.006%). This missense change has been observed in individuals with clinical features of spinocerebellar ataxia (PMID: 25089919, 34234304). ClinVar contains an entry for this variant (Variation ID: 446836). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ANO10 protein function. Experimental studies have shown that this missense change affects ANO10 function (PMID: 32620747). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
| Gene |
RCV003558436 | SCV005437452 | uncertain significance | not provided | 2024-06-10 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27142713, 32620747, 25089919, 37152446, 34234304) |
| Fulgent Genetics, |
RCV000778699 | SCV005664521 | likely pathogenic | Autosomal recessive spinocerebellar ataxia 10 | 2024-06-14 | criteria provided, single submitter | clinical testing |